Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years
Clinical trial NCT00309634 · COMPLETED
Trial details
- NCT number
- NCT00309634
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-27
- Primary completion
- 2006-10-28
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.